-
Mylan receives DCGI approval in India for TB drug, Pretomanid
expresspharma
July 23, 2020
Pretomanid is only the third new anti-tuberculosis (TB) drug developed specifically for drug-resistant forms of the disease to be approved in more than 40 years.
-
J&J drops TB drug price following mass petition
expresspharma
July 08, 2020
Médecins Sans Frontières insisted that prices should come further down from the revised price of the drug, bedaquiline, hailed as the backbone of DR-TB treatment by WHO.
-
Amgen Is Supporting Advancement Of AMG 634 For Global Health Diseases In Developing Countries
prnewswire
June 23, 2020
Amgen announced it is supporting the further study of AMG 634, a phosphodiesterase type 4 (PDE4) inhibitor, for the treatment of tuberculosis (TB) and erythema nodosum leprosum (ENL), an inflammatory cutaneous and systemic complication of leprosy.
-
Why are children waiting so long for new meds?
expresspharma
June 10, 2020
COVID-19 and drug resistance are threatening to derail the progress made against the HIV, malaria and TB epidemics, and this may have a negative impact on child healthcare: Access to Medicine Foundation.
-
Global collaboration formed to develop novel treatment regimens for TB
europeanpharmaceuticalreview
March 03, 2020
The Project to Accelerate New Treatments for Tuberculosis (PAN-TB collaboration) was devised to create transformative regimens for TB treatment, irrespective of drug resistance status.
-
Intravenous delivery of TB vaccine found to dramatically improve potency in models
europeanpharmaceuticalreview
January 03, 2020
New research has shown that intravenous injection of the BCG vaccine dramatically reduces monkey susceptibility to TB bacteria and lung inflammation.
-
J&J commits $500M investment to end TB, HIV
biospectrumasia
October 08, 2019
As part of the $500 million investment, Janssen will continue to advance an investigational mosaic-based vaccine regimen to prevent HIV together with a consortium of partners.
-
12.6 Million in U.S. Could Benefit From Tx to Prevent Active TB
drugs
September 19, 2019
According to a report put out the October issue of the Journal of New Infectious Diseases published by the Centers for Disease Control and Prevention, an estimated 12.6 million persons in the United States could ...
-
TB Cases Drop Among the Young, But Racial Disparities Persist
drugs
August 23, 2019
There's good and bad news in a new report on tuberculosis rates among American children and teens: Overall, the number of cases have fallen by nearly half, but they still remain much higher among minorities than whites.
-
FDA Approves New Treatment for Drug-Resistant TB
contractpharma
August 16, 2019
Pretomanid is only the third new anti-TB drug approved by FDA in more than 40 years.